DexCom, Inc. (DXCM)
USD 61.8
(-9.3%)
USD 61.8
(-9.3%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 597.7 Million USD | 52.79% |
| 2022 | 391.2 Million USD | 123.03% |
| 2021 | 175.4 Million USD | -41.44% |
| 2020 | 299.5 Million USD | 110.47% |
| 2019 | 142.3 Million USD | 176.38% |
| 2018 | -186.3 Million USD | -338.35% |
| 2017 | -42.5 Million USD | 33.49% |
| 2016 | -63.9 Million USD | -11.91% |
| 2015 | -57.1 Million USD | -165.58% |
| 2014 | -21.5 Million USD | 25.61% |
| 2013 | -28.9 Million USD | 48.11% |
| 2012 | -55.7 Million USD | -24.21% |
| 2011 | -44.84 Million USD | 0.99% |
| 2010 | -45.29 Million USD | 1.18% |
| 2009 | -45.83 Million USD | 13.24% |
| 2008 | -52.82 Million USD | -13.18% |
| 2007 | -46.67 Million USD | 5.36% |
| 2006 | -49.32 Million USD | -52.08% |
| 2005 | -32.42 Million USD | -130.53% |
| 2004 | -14.06 Million USD | -38.12% |
| 2003 | -10.18 Million USD | -61.38% |
| 2002 | -6.31 Million USD | 6.14% |
| 2001 | -6.72 Million USD | -67.51% |
| 2000 | -4.01 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 158 Million USD | 56.28% |
| 2024 Q3 | 152 Million USD | -3.8% |
| 2024 Q1 | 101.1 Million USD | -53.39% |
| 2023 Q4 | 216.9 Million USD | 5.55% |
| 2023 Q1 | 69.1 Million USD | -44.9% |
| 2023 Q2 | 128.1 Million USD | 85.38% |
| 2023 Q3 | 205.5 Million USD | 60.42% |
| 2023 FY | 597.7 Million USD | 52.79% |
| 2022 Q4 | 125.4 Million USD | -14.98% |
| 2022 FY | 391.2 Million USD | 123.03% |
| 2022 Q1 | 41.3 Million USD | 6783.33% |
| 2022 Q2 | 77 Million USD | 86.44% |
| 2022 Q3 | 147.5 Million USD | 91.56% |
| 2021 Q2 | 101 Million USD | 120.04% |
| 2021 Q3 | 118.3 Million USD | 17.13% |
| 2021 Q1 | 45.9 Million USD | -55.87% |
| 2021 FY | 175.4 Million USD | -41.44% |
| 2021 Q4 | 600 Thousand USD | -99.49% |
| 2020 Q4 | 104 Million USD | 10.52% |
| 2020 Q1 | 33.6 Million USD | -66.9% |
| 2020 Q3 | 94.1 Million USD | 38.79% |
| 2020 FY | 299.5 Million USD | 110.47% |
| 2020 Q2 | 67.8 Million USD | 101.79% |
| 2019 Q2 | -800 Thousand USD | 94.44% |
| 2019 FY | 142.3 Million USD | 176.38% |
| 2019 Q4 | 101.5 Million USD | 81.25% |
| 2019 Q1 | -14.4 Million USD | 91.25% |
| 2019 Q3 | 56 Million USD | 7100.0% |
| 2018 FY | -186.3 Million USD | -338.35% |
| 2018 Q1 | -30.7 Million USD | -355.83% |
| 2018 Q2 | -4.9 Million USD | 84.04% |
| 2018 Q3 | 13.9 Million USD | 383.67% |
| 2018 Q4 | -164.6 Million USD | -1284.17% |
| 2017 Q2 | -13.6 Million USD | 66.34% |
| 2017 Q3 | -500 Thousand USD | 96.32% |
| 2017 FY | -42.5 Million USD | 33.49% |
| 2017 Q4 | 12 Million USD | 2500.0% |
| 2017 Q1 | -40.4 Million USD | -562.3% |
| 2016 Q3 | -18.5 Million USD | 7.96% |
| 2016 Q2 | -20.1 Million USD | -4.69% |
| 2016 Q4 | -6.1 Million USD | 67.03% |
| 2016 FY | -63.9 Million USD | -11.91% |
| 2016 Q1 | -19.2 Million USD | -1300.0% |
| 2015 FY | -57.1 Million USD | -165.58% |
| 2015 Q4 | 1.6 Million USD | 103.77% |
| 2015 Q3 | -42.4 Million USD | -1077.78% |
| 2015 Q2 | -3.6 Million USD | 71.65% |
| 2015 Q1 | -12.7 Million USD | -893.75% |
| 2014 Q3 | -5 Million USD | 13.79% |
| 2014 Q4 | 1.6 Million USD | 132.0% |
| 2014 FY | -21.5 Million USD | 25.61% |
| 2014 Q1 | -12.3 Million USD | -434.78% |
| 2014 Q2 | -5.8 Million USD | 52.85% |
| 2013 FY | -28.9 Million USD | 48.11% |
| 2013 Q4 | -2.3 Million USD | 60.34% |
| 2013 Q2 | -9.9 Million USD | 9.17% |
| 2013 Q1 | -10.9 Million USD | -30.82% |
| 2013 Q3 | -5.8 Million USD | 41.41% |
| 2012 Q3 | -17.32 Million USD | -18.25% |
| 2012 Q2 | -14.64 Million USD | 4.86% |
| 2012 Q1 | -15.39 Million USD | -25.42% |
| 2012 FY | -55.7 Million USD | -24.21% |
| 2012 Q4 | -8.33 Million USD | 51.9% |
| 2011 Q4 | -12.27 Million USD | 7.75% |
| 2011 Q3 | -13.3 Million USD | -80.11% |
| 2011 Q2 | -7.38 Million USD | 37.75% |
| 2011 Q1 | -11.87 Million USD | -20.07% |
| 2011 FY | -44.84 Million USD | 0.99% |
| 2010 Q2 | -11.26 Million USD | -1.75% |
| 2010 Q1 | -11.07 Million USD | -17.04% |
| 2010 Q4 | -9.88 Million USD | 24.31% |
| 2010 Q3 | -13.06 Million USD | -15.92% |
| 2010 FY | -45.29 Million USD | 1.18% |
| 2009 Q3 | -11.57 Million USD | 13.94% |
| 2009 FY | -45.83 Million USD | 13.24% |
| 2009 Q4 | -9.46 Million USD | 18.28% |
| 2009 Q2 | -13.45 Million USD | -18.68% |
| 2009 Q1 | -11.33 Million USD | 11.0% |
| 2008 Q4 | -12.73 Million USD | 8.95% |
| 2008 FY | -52.82 Million USD | -13.18% |
| 2008 Q2 | -13.45 Million USD | -6.41% |
| 2008 Q1 | -12.64 Million USD | -3.84% |
| 2008 Q3 | -13.99 Million USD | -3.98% |
| 2007 Q1 | -11.45 Million USD | 2.56% |
| 2007 Q2 | -11.54 Million USD | -0.73% |
| 2007 Q3 | -11.5 Million USD | 0.32% |
| 2007 Q4 | -12.17 Million USD | -5.86% |
| 2007 FY | -46.67 Million USD | 5.36% |
| 2006 Q4 | -11.75 Million USD | 17.53% |
| 2006 FY | -49.32 Million USD | -52.08% |
| 2006 Q3 | -14.25 Million USD | -19.74% |
| 2006 Q2 | -11.9 Million USD | -4.41% |
| 2006 Q1 | -11.4 Million USD | 9.54% |
| 2005 Q1 | -6.12 Million USD | 0.0% |
| 2005 Q4 | -12.6 Million USD | -83.71% |
| 2005 Q3 | -6.86 Million USD | -0.28% |
| 2005 Q2 | -6.84 Million USD | -11.77% |
| 2005 FY | -32.42 Million USD | -130.53% |
| 2004 FY | -14.06 Million USD | -38.12% |
| 2003 FY | -10.18 Million USD | -61.38% |
| 2002 FY | -6.31 Million USD | 6.14% |
| 2001 FY | -6.72 Million USD | -67.51% |
| 2000 FY | -4.01 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 4261.966% |
| Cerus Corporation | -30.05 Million USD | 2088.82% |
| OrthoPediatrics Corp. | -25.76 Million USD | 2419.724% |
| PetVivo Holdings, Inc. | -10.62 Million USD | 5727.35% |
| Talis Biomedical Corporation | -66.81 Million USD | 994.56% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 3555.712% |
| Inogen, Inc. | -109.38 Million USD | 646.414% |
| Spectral AI, Inc. | -12.98 Million USD | 4703.358% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 1054.96% |
| CVRx, Inc. | -43.1 Million USD | 1486.678% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 17041.61% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | 4909.302% |
| Orthofix Medical Inc. | -139.11 Million USD | 529.66% |
| Venus Concept Inc. | -28.3 Million USD | 2211.343% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 1206.278% |
| Bioventus Inc. | -81.72 Million USD | 831.355% |
| BrainsWay Ltd. | -4.92 Million USD | 12231.114% |
| Envoy Medical, Inc. | -18.37 Million USD | 3353.497% |
| electroCore, Inc. | -18.8 Million USD | 3278.41% |
| IceCure Medical Ltd | -15.57 Million USD | 3937.314% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 1332.829% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 3561.31% |
| MaxCyte, Inc. | -48.29 Million USD | 1337.5% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | 5099.477% |
| Nexalin Technology, Inc. | -5.69 Million USD | 10592.783% |
| PAVmed Inc | -68.79 Million USD | 968.813% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 1156.698% |
| RxSight, Inc. | -50.08 Million USD | 1293.371% |
| Sight Sciences, Inc. | -57.27 Million USD | 1143.58% |
| SI-BONE, Inc. | -46.93 Million USD | 1373.572% |
| TELA Bio, Inc. | -44.07 Million USD | 1456.098% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 1203.786% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 1262.207% |
| LivaNova PLC | -68.49 Million USD | 972.58% |
| 908 Devices Inc. | -42.75 Million USD | 1497.867% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 444.704% |
| Nemaura Medical Inc. | -9.59 Million USD | 6329.134% |
| NeuroPace, Inc. | -27.17 Million USD | 2299.529% |
| LENSAR, Inc. | -12.22 Million USD | 4987.562% |
| Apyx Medical Corporation | -17.25 Million USD | 3563.121% |
| Cutera, Inc. | -156.23 Million USD | 482.577% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | 7046.769% |
| BioSig Technologies, Inc. | -28.51 Million USD | 2196.31% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 782.002% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 2762.835% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | -435.929% |
| Axonics, Inc. | -26.05 Million USD | 2393.817% |
| Outset Medical, Inc. | -169.77 Million USD | 452.065% |
| IRIDEX Corporation | -10 Million USD | 6072.819% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 647.495% |
| IRadimed Corporation | 20.03 Million USD | -2883.211% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 7349.243% |
| INVO Bioscience, Inc. | -6.76 Million USD | 8932.368% |
| Telesis Bio, Inc. | -35.15 Million USD | 1800.427% |
| Viemed Healthcare, Inc. | 14.33 Million USD | -4070.97% |
| Varex Imaging Corporation | 32.1 Million USD | -1761.994% |
| Quipt Home Medical Corp. | 3.91 Million USD | -15151.34% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 5026.234% |
| Pulmonx Corporation | -61.93 Million USD | 1065.044% |
| Dynatronics Corporation | -2.27 Million USD | 26395.089% |
| Modular Medical, Inc. | -17.52 Million USD | 3509.778% |
| ReShape Lifesciences Inc. | -14.63 Million USD | 4182.929% |
| Semler Scientific, Inc. | 22.25 Million USD | -2585.568% |
| InMode Ltd. | 195.66 Million USD | -205.479% |
| Bruker Corporation | 436.9 Million USD | -36.805% |
| Cytosorbents Corporation | -31.2 Million USD | 2015.137% |
| Align Technology, Inc. | 643.33 Million USD | 7.094% |
| Viveve Medical, Inc. | -21.55 Million USD | 2873.164% |
| ZimVie Inc. | -30.93 Million USD | 2031.866% |
| Movano Inc. | -29.69 Million USD | 2113.136% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 2246.525% |
| Nexalin Technology, Inc. | -5.69 Million USD | 10592.783% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 17041.61% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 356.271% |
| Profound Medical Corp. | -28.61 Million USD | 2188.692% |
| Insulet Corporation | 220 Million USD | -171.682% |
| enVVeno Medical Corporation | -25.23 Million USD | 2468.254% |
| Surmodics, Inc. | -5.64 Million USD | 10688.131% |
| iCAD, Inc. | -7.68 Million USD | 7873.443% |
| Nuwellis, Inc. | -17.63 Million USD | 3490.244% |
| Biotricity, Inc. | -8.82 Million USD | 6870.297% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 577.545% |
| Aethlon Medical, Inc. | -12.63 Million USD | 4829.924% |
| InspireMD, Inc. | -21.14 Million USD | 2926.94% |
| PAVmed Inc. | -68.79 Million USD | 968.813% |
| BIOLASE, Inc. | -17.93 Million USD | 3432.218% |
| Beyond Air, Inc. | -63 Million USD | 1048.64% |
| FONAR Corporation | 16.53 Million USD | -3514.677% |
| AxoGen, Inc. | -21.46 Million USD | 2884.922% |
| Vivani Medical, Inc. | -26.96 Million USD | 2316.577% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | -3213.009% |
| Inari Medical, Inc. | -14.03 Million USD | 4359.55% |
| UFP Technologies, Inc. | 57.66 Million USD | -936.522% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | 12229.637% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | 9578.62% |
| Tenon Medical, Inc. | -15.72 Million USD | 3900.471% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | 8097.056% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 1499.561% |
| AdaptHealth Corp. | -598.4 Million USD | 199.883% |
| Sintx Technologies, Inc. | -13.35 Million USD | 4574.472% |
| NanoVibronix, Inc. | -3.43 Million USD | 17495.227% |
| Quanterix Corporation | -49.7 Million USD | 1302.591% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 5026.234% |
| Sensus Healthcare, Inc. | -382 Thousand USD | 156565.969% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 278.702% |
| TransMedics Group, Inc. | -28.72 Million USD | 2180.621% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 2631.34% |
| NeuroMetrix, Inc. | -7.15 Million USD | 8457.663% |
| Hyperfine, Inc. | -48.11 Million USD | 1342.232% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 1019.171% |
| Biomerica, Inc. | -6.36 Million USD | 9487.467% |
| Bone Biologics Corporation | -9.42 Million USD | 6439.423% |
| AVITA Medical, Inc. | -40.4 Million USD | 1579.379% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | 5896.601% |
| Silk Road Medical, Inc | -59.27 Million USD | 1108.419% |